Given that this latest denial of STEM by the court looks like it could lose them the case they will want to delay the inevitable as long as possible
Your forgot about the "head and shoulders"
I like when the stock jumps up and they insist there are "gaps" that need to be filled before it can go higher.
I agree that 1 share shares should not be allowed. There are those also that take advantage of inexperienced traders that put in market orders after hours but I do think stopping it altogether would be wise.
The kick in the ba11s for him is that he dumped a large portion (if not all) before this recent run which is likely to continue.
I've been here much longer than that. I bought 15+ years ago (l've lost count). I bought 100 shares not too long out of college when I had little cash. I bought it at $7. I figured if a company could cure people with stem cells 100 shares would be enough to have a big pay day. As time went on I made much larger investments in other stocks and the account I had my Geron shares in I stopped looking at. It wasn't until after the fact I realized the PPS has gone to $73 at one point. I currently have a core position of 20k and trade in/out of other shares. I do believe for the first time that there is little downside on this stock and will be sitting tight. J&J/Janssen know how to pick winners in the oncology area. I'm looking at this paying out in 3 years with some volatility along the way but I see little chance of Imetelstat failing.
I prefer to believe the patent troll pumper as opposed to verified facts.
Pretty sad when you consider several hundred million dollars of investor money has been dumped into STEM
INCY doesn't have the kind of cash the J&J does but with a $12 billion market cap they could use their shares in an acquisition.
Can you throw it in the dishwasher when you are done ? LOL
INCY is the most threatened by Imetelstat. If anyone would want to come in during the 30 day window it would be them.
Taz, Good job posting this on the INCY board. I'm sure the Jackofv crowd will love you for it.
Hatchet or no hatchet we know West was taking the company in a million directions just as he is at Biotime and he makes zero progress. Geron was not focused like a small biotech should be until Chip came on board.
Maybe while the Mayo abstract is being presented the patients could be along side the podium getting infused with Imetelstat. That would make for a great prop.